Emergency Department Visits for Emesis Following Chemotherapy: Guideline Nonadherence, OP-35, and a Path Back to the Future-Reference-Cited by-同舟云学术

Emergency Department Visits for Emesis Following Chemotherapy: Guideline Nonadherence, OP-35, and a Path Back to the Future

Published:2021-03-04 Issue:4 Volume:26 Page:274-276
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Neugut Alfred I.¹,Bates Susan E.¹

Affiliation:

1. Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA

Abstract

Better adherence to supportive care guidelines is needed, especially for common challenges such as chemotherapy-induced nausea and vomiting. This commentary remarks on recently published data on adherence to guidelines, considering treatment options and new strategies to reduce chemotherapy complications.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/onco.13681

Reference20 articles.

1. Avoidable acute care use associated with nausea and vomiting among patients receiving highy emetogenic chemotherapy or oxaliplatin;Navari;The Oncologist,2020

2. Best practices for reducing unplanned acute care for patients with cancer;Handley;J Oncol Pract,2018

3. Nausea and Vomiting in the Cancer Patient

4. ASCO, NCCN, MASCC/ESMO: A comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients;Razvi;Support Care Cancer,2019

5. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone;Campos;J Clin Oncol,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information;Experimental Hematology & Oncology;2022-10-31

2. Cancer-related emergency and urgent care: expanding the research agenda;Emergency Cancer Care;2022-06-14

3. Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy;The Oncologist;2021-02-26